SCHEMBL22097099

SCHEMBL22097099

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)c3ccccc3c3cc5c6cc7c8ccccc8c8ccccc8c7cc6n(-c6ccccc6)c5cc43)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
ABCG2 Q9UNQ0 3/20 0.38
AVPR1A P37288 1/20 0.36
PTGER4 P35408 1/20 0.36
MAT2A P31153 2/20 0.36
PRMT5 O14744 1/20 0.36
MAPK1 P28482 2/20 0.35
NTSR1 P30989 1/20 0.35
RXRA P19793 1/20 0.34
LMNA P02545 2/20 0.34
GLA P06280 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22096993 1.00 KDM4E (0.41) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL22097078 0.96 L3MBTL1 (0.49) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL14728161 0.96 L3MBTL1 (0.49) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL16362439 0.96 L3MBTL1 (0.43) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL22097263 0.95 L3MBTL1 (0.47) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL22096961 0.95 L3MBTL1 (0.47) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17736910 0.92 L3MBTL1 (0.45) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17736922 0.92 L3MBTL1 (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL21863067 0.90 L3MBTL1 (0.51) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL23156430 0.90 L3MBTL1 (0.45) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236075-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-02-01 US disclosed
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11236075-B2 Organic compound and organic electroluminescence device using the same ICMT, OR10J3, PIEZO1 KDM4E 1846/4885ATM 3884/4885L3MBTL1 179/4885
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 KDM4E 1846/4885ATM 3884/4885L3MBTL1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.